Comparison of exercise-rest-reinjection Tl-201 imaging and rest sublingual isosorbide dinitrate Tc-99m MIBI imaging for the assessment of myocardial viability
Tóm tắt
Từ khóa
Tài liệu tham khảo
Pigott JD, Kouchoukos NT, Oberman A, Cutter GR. Late results of surgical and medical therapy in patients with coronary artery disease and depressed left ventricular function. J Am Coll Cardiol. 1985;5:1036–45.
Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M, et al. Reversibility of reversible cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med. 1986;3(314):884–8.
Dilsizian V, Rocco TP, Freedman NM, Leon MB, Bonow RO. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med. 1990;323:141–6.
Kayden DS, Sigal S, Soufer R, Mattera J, Zaret BL, Wackers FJ. Thallium-201 for assessment of myocardial viability: quantitative comparison of 24-hour redistribution imaging with imaging after reinjection at rest. J Am Coll Cardiol. 1991;18:1480–6.
Dilsizian V, Perrone-Filardi P, Arrighi JA, Bacharach SL, Quyyumi AA, Freedman NM, et al. Concordance and discordance between stress-redistribution-reinjection and rest- redistribution thallium imaging for assessing viable myocardium: comparison with metabolic activity by PET. Circulation. 1993;88:941–52.
Rocco TP, Dilsizian V, Strauss HW, Boucher CA. Technetium-99m isonitrile myocardial uptake at rest: II. relation to clinical markers of potential viability. J Am Coll Cardiol. 1989;14:1678–84.
Cuocolo A, Pace L, Ricciardelli B, Chiariello M, Trimarco B, Salvatore M. Identification of viable myocardium in patients with chronic coronary artery disease: Comparison of thallium-201 scintigraphy with reinjection and technetium-99 methoxyisobutyl isonitrile. J Nucl Med. 1992;33:505–11.
Dilsizian V, Arrighi JA, Diodati JG, Quyyumi AA, Alavi K, Bacharach SL, et al. Myocardial viability in patients with chronic coronary artery disease: comparison of Tc-99m-sestamibi with thallium reinjection and F-fluorodeoxyglucose. Circulation. 1994;89:578–87.
Sawada SG, Allman KC, Muzik O, Beanlands RS, Wolfe ER Jr, Gross M, et al. Positron emission tomography detects evidence of viability in rest technetium-99m sestamibi defects. J Am Coll Cardiol. 1994;23:92–8.
Bisi G, Sciagra R, Santoro GM, Zerauschek F, Fazzini PF. Sublingual isosorbide dinitrate to improve technetium-99m-teboroxime perfusion defect reversibility. J Nucl Med. 1994;35:1274–8.
He ZX, Darcourt J, Guigner A, Ferrari E, Bussiere F, Baudouy M, et al. Nitrates improve detection of ischemic but viable myocardium by thallium-201 reinjection SPECT. J Nucl Med. 1993;34:1472–7.
Bisi G, Sciagra R, Santoro GM, Rozzi V, Fazzini PF. Technetium-99m-sestamibi imaging with nitrate infusion to detect viable hibernating myocardium and predict postrevascularization recovery. J Nucl Med. 1995;36:1994–2000.
Sciagra R, Bisi G, Santoro GM, Zerauschek F, Sestini S, Pedenovi P, et al. Comparison of baseline-nitrate technetium-99m sestamibi with rest-redistribution thallium-201 tomography in detecting viable hibernating myocardium and predicting postrevascularization recovery. J Am Coll Cardiol. 1997;30:384–91.
O’Connor MK, Hammell T, Gibbons RJ. In vitro validation of a simple tomographic technique for estimation of percentage myocardium at risk using methoxyisobutylisonitrile technetium-99m (sestamibi). Eur J Nucl Med. 1990;17:69–76.
Kauffman GJ, Boyne TS, Watson DD, Smith WH, Beller GA. Comparison of rest thallium-201 imaging and rest scintigraphy technetium-99m sestamibi imaging for assessment of myocardial viability in patients with coronary artery disease and severe left ventricular dysfunction. J Am Coll Cardiol. 1996;27:1592–7.
Flotats A, Carrio I, Estorch M, Berna L, Catafau AM, Mari C, et al. Nitrate administration to enhance the detection of myocardial viability by technetium-99m-tetrafosmin single-photon emission tomography. Eur J Nucl Med. 1997;24:767–73.
Badger RD, Brown BG, Gallery CA, Bolson EL, Dodge HT. Coronary artery dilation and hemodynamic responses after isosorbide dinitrate therapy in patients with coronary artery disease. Am J Cardiol. 1985;56:390–5.
Udelson JE, Coleman PS, Metherall J, Pandian NG, Gomez AR, Griffith JL, et al. Predicting recovery of severe regional ventricular dysfunction: comparison of resting scintigraphy with Tl-201 and Tc99m-sestamibi. Circulation. 1994;89:2552–61.
Brown BG, Bolson E, Petersen RB, Pierce CD, Dodge HT. The mechanisms of nitroglycerin action: stenosis vasodilation as a major component of the drug response. Circulation. 1981;64:1089–97.
Othani H, Tamaki N, Yonekura Y, Mohiuddin IH, Hirata K, Ban T, et al. Value of thallium-201 reinjection after delayed SPECT imaging for predicting reversible ischemia after coronary artery by-pass grafting. Am J Cardiol. 1990;66:394–9.
Rocco TP, Dilsizian V, McKusick KA, Fischman AJ, Boucher CA, Strauss HW. Comparison of thallium redistribution with rest “reinjection” imaging for the detection of viable myocardium. Am J Cardiol. 1990;66:158–63.
Tamaki N, Ohtani H, Yamashita K, Magata Y, Yonekura Y, Nohara R, et al. Metabolic activity in the areas of new fill-in after thallium-201 reinjection: Comparison with positron emission tomography using fluorine-18-deoxyglucose. J Nucl Med. 1991;32:673–8.
Maurea S, Cuocolo A, Soricelli A, Castelli L, Nappi A, Squame F, et al. Enhanced detection of viable myocardium by technetium-99m-MIBI imaging after nitrate administration in chronic coronary artery disease. J Nucl Med. 1995;36:1945–52.